Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia

Hematopoietic stem cell transplantation (HSCT) is a critical treatment modality for many hematological and non-hematological diseases that is being extended to treat older individuals. However, recent studies show that clonal hematopoiesis of indeterminate potential (CHIP), a common, asymptomatic co...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Sarah S., Kapur, Reuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419737/
https://www.ncbi.nlm.nih.gov/pubmed/32783925
http://dx.doi.org/10.1016/j.stemcr.2020.07.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419737/
https://www.ncbi.nlm.nih.gov/pubmed/32783925
http://dx.doi.org/10.1016/j.stemcr.2020.07.008

Ejemplares similares